Roche Pegasys/Copegus Monitoring For Severe Infections Advised By Cmte.

Hepatitis C patients receiving Roche's Pegasys/ Copegus should be actively monitored for hematologic abnormalities and infections, FDA's Antiviral Drugs Advisory Committee recommended Nov. 14